Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Alessandra Barraco"'
Autor:
Alessandra Barraco, Eduard Vieta, Catherine Reed, Ana González-Pinto, Jaume Aguado, Diego Novick, Josep Maria Haro
Publikováno v:
Journal of Affective Disorders. 131:320-329
Background This study compared the 2-year outcomes of patients with a manic/mixed episode of bipolar disorder taking olanzapine monotherapy or olanzapine in combination with other agents. Methods EMBLEM (European Mania in Bipolar Longitudinal Evaluat
Publikováno v:
CNS Neuroscience & Therapeutics. 18:110-118
SUMMARY Background: In patients with bipolar disorder, medication is effective in preventing relapses. Unfortunately, adherence to treatment in bipolar disorder, as in other chronic or recurrent conditions, is not optimal. Estimates of nonadherence t
Publikováno v:
CNS neurosciencetherapeutics. 18(2)
Background: In patients with bipolar disorder, medication is effective in preventing relapses. Unfortunately, adherence to treatment in bipolar disorder, as in other chronic or recurrent conditions, is not optimal. Estimates of nonadherence to prescr
Publikováno v:
Annals of General Psychiatry
Annals of General Psychiatry, Vol 9, Iss 1, p 33 (2010)
Annals of General Psychiatry, Vol 9, Iss 1, p 33 (2010)
Background Factors Influencing Depression Endpoints Research (FINDER) is a 6-month, prospective, observational study carried out in 12 European countries aimed at investigating health-related quality of life (HRQoL) in outpatients receiving treatment
Publikováno v:
BMC Psychiatry, Vol 7, Iss 1, p 33 (2007)
BMC Psychiatry
BMC Psychiatry
Background Although a number of studies have assessed the management of mania in routine clinical practice, no studies have so far evaluated the short- and long-term management and outcome of patients affected by bipolar mania in different European c
Publikováno v:
Annals of General Hospital Psychiatry
Background Fluoxetine was the first molecule of a new generation of antidepressants, the Selective Serotonin Re-uptake Inhibitors (SSRIs). It is recurrently the paradigm for the development of any new therapy in the treatment of depression. Many cont
Publikováno v:
Schizophrenia Research. 117:264-265
Autor:
Cesare Maffei, Maria Bagnato, Ilaria Agostoni, Alessandra Barraco, Donati Deborah, Andrea Fossati, Liliana Novella, Monica Petrachi, Caterina Namia
Publikováno v:
Scopus-Elsevier
Interrater reliability and internal consistency of the SCID-II 2.0 was assessed in a sample of 231 consecutively admitted in- and outpatients using a pairwise interview design, with randomized rater pairing and blind interview assessment. Interrater
Publikováno v:
Annals of General Hospital Psychiatry. 3:2
Fluoxetine was the first molecule of a new generation of antidepressants, the Selective Serotonin Re-uptake Inhibitors (SSRIs). It is recurrently the paradigm for the development of any new therapy in the treatment of depression. Many controlled stud